Results 11 to 20 of about 1,967,846 (356)

Survival of retinoblastoma patients: a cohort study by two Russian medical centers

Российский офтальмологический журнал, 2021
Purpose. To evaluate the overall, disease-specific, event-free, relapse-free survival of retinoblastoma (RB) patients and cumulative probability of eye survival in such patients.Material and methods.
S. V. Saakyan, O. A. Ivanova, S. S. Tadevosyan, A. Yu. Tsygankov, L. V. Olkhova, T. L. Ushakova, V. G. Polyakov   +6 more
doaj   +1 more source

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate

Journal of Oncology, 2022
Objectives. Ameloblastoma is a slow-growing epithelial odontogenic neoplasm of the jaws with a high recurrence rate. The main treatment strategies for this lesion are radical or conservative surgical approaches. The aim of the present study was to analyze clinical presentations, histological types, and treatment strategies of recurrent ameloblastoma ...
Andrii Hresko, Roman Palyvoda, Olha Burtyn, Yurii Chepurnyi, Andrii Kopchak, Marco Helder, Tymour Forouzanfar   +6 more
openaire   +4 more sources

MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients [PDF]

International Journal of Medical Sciences, 2021
Objective: This study aimed to investigate the roles of MRPL27 in survival from cholangiocarcinoma patients in The Cancer Genome Atlas (TCGA) database. Methods: In TCGA-CHOL profile, MRPL27 gene expression and clinical data were obtained. Cox regression models were used to evaluate the potential links between MRPL27 and cholangiocarcinoma survival ...
Zhuang, Liping, Meng, Zhiqiang, Yang, Zongguo   +2 more
openaire   +2 more sources

Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study

Gut and Liver, 2023
Background/Aims: Owing to the low prevalence of small-bowel adenocarcinoma (SBA), data on the impact of Crohn’s disease (CD) on the survival of patients with SBA are lacking. Therefore, we investigated this issue in this study.
Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park, IBD Research Group of the Korean Association for the Study of Intestinal Diseases   +10 more
doaj   +1 more source

The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant)

Cancer Cell International, 2021
Purpose An increasing number of studies have reported a significant association between long non-coding RNAs (lncRNAs) dysregulation and pancreatic cancers.
Elahe Seyed Hosseini, Ali Nikkhah, Amir Sotudeh, Marziyeh Alizadeh Zarei, Fatemeh Izadpanah, Hossein Nikzad, Hamed Haddad Kashani   +6 more
doaj   +1 more source

Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases. [PDF]

PLoS ONE, 2017
INTRODUCTION:Pulmonary mucoepidermoid carcinoma is a rare cancer that occurs primarily in younger patients. The prognostic factors of pulmonary mucoepidermoid carcinoma are largely undetermined, especially in elderly patients.
Chih-Cheng Hsieh, Yung-Han Sun, Shih-Wei Lin, Yi-Chen Yeh, Mei-Lin Chan   +4 more
doaj   +1 more source

Long-term disease-free survival in acute nonlymphocytic leukemia [PDF]

Blood, 1981
Abstract Twenty-six of 45 adults (58%) with acute nonlymphocytic leukemia who were treated with intensive induction chemotherapy over 5 yr ago entered complete remission. All patients entering remission were placed on weekly maintenance chemotherapy consisting of cytosine arabinoside and 6-thioguanine.
B A, Peterson, C D, Bloomfield
openaire   +3 more sources

Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network [PDF]

, 2011
Clinically and biologically, nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has much more in common with germinal-center derived B-cell non-Hodgkin lymphoma (NHL) than with classical Hodgkin lymphoma (cHL).
Diehl V, Fanale MA, Hasenclever D, Katrina Farrell, Mike Leach, Orlandi E, Pamela Mckay, Savage KJ, Stein H   +8 more
core   +1 more source

Cyclin D3 predicts disease-free survival in breast cancer [PDF]

Cancer Cell International, 2015
Cyclin D3, which induces progression through the G1 phase of the cell cycle, is a regulator of Cyclin-dependent kinases 4 and 6. Previous studies revealed that abnormal expression of Cyclin D3 was found in many different cancers. However, the role of Cyclin D3 in breast cancer (BC) remains unknown.
Chi, Yayun, Huang, Sheng, Liu, Mengying, Guo, Liang, Shen, Xuxia, Wu, Jiong   +5 more
openaire   +2 more sources

Circulating cell death products predict clinical outcome of colorectal cancer patients. [PDF]

, 2009
BackgroundTumor cell death generates products that can be measured in the circulation of cancer patients. CK18-Asp396 (M30 antigen) is a caspase-degraded product of cytokeratin 18 (CK18), produced by apoptotic epithelial cells, and is elevated in breast ...
Hommes, Daan W, Koelink, Pim J, Lamers, Cornelis Bhw, Verspaget, Hein W   +3 more
core   +2 more sources